Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Estrogen Receptor-positive Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Letrozole 2.5mg
Sponsor: Cairo University